Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2008
|
| _version_ | 1797103863456595968 |
|---|---|
| author | Heymach, J Hanrahan, E Mann, H Langmuir, P Natale, R Johnson, B Herbst, R Ryan, A |
| author_facet | Heymach, J Hanrahan, E Mann, H Langmuir, P Natale, R Johnson, B Herbst, R Ryan, A |
| author_sort | Heymach, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:26:02Z |
| format | Journal article |
| id | oxford-uuid:f4526b1c-f4b7-43d4-a931-58c7aaa75c4b |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:26:02Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:f4526b1c-f4b7-43d4-a931-58c7aaa75c4b2022-03-27T12:18:58ZBaseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLCJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f4526b1c-f4b7-43d4-a931-58c7aaa75c4bSymplectic Elements at Oxford2008Heymach, JHanrahan, EMann, HLangmuir, PNatale, RJohnson, BHerbst, RRyan, A |
| spellingShingle | Heymach, J Hanrahan, E Mann, H Langmuir, P Natale, R Johnson, B Herbst, R Ryan, A Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title | Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title_full | Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title_fullStr | Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title_full_unstemmed | Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title_short | Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC |
| title_sort | baseline vegf as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced nsclc |
| work_keys_str_mv | AT heymachj baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT hanrahane baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT mannh baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT langmuirp baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT nataler baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT johnsonb baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT herbstr baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc AT ryana baselinevegfasapotentialpredictivebiomarkerofvandetanibclinicalbenefitinpatientswithadvancednsclc |